A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis

Author:

Espi Maxime,Charmetant XavierORCID,Barba Thomas,Mathieu Cyrille,Pelletier Caroline,Koppe LaetitiaORCID,Chalencon Elodie,Kalbacher Emilie,Mathias Virginie,Ovize Anne,Cart-Tanneur Emmanuelle,Bouz Christine,Pellegrina Laurence,Morelon Emmanuel,Juillard Laurent,Fouque Denis,Couchoud CécileORCID,Thaunat Olivier,François Chantrel,Mathilde Reydit,Aurélien Tiple,Clémence Bechade,Abdelkader Bemrah,Cécile Vigneau,Bénédicte Sautenent,Isabelle Kazes,Cécile Courivaud,Jean-Marc Gabriel,Stéphane Edet,Lucile Mercadal,Olivier Moranne,Fatouma Toure,Emmanuelle Laurain,Alex Ranlin,Nathalie Longlune,François Glowacki,Jean-Michel Tivollier,Philippe Brunet,Fréderic Lavainne,Etienne Berard,Ayman Sarraj,Marc Bauwens,Pascale Testevuide,Henri Vacher Coponat,Roula Galland,Nicole Schauder,Louis -Rachid Salmi,Damiano Cerasuolo,Anaïs Tendron-Franzin,Sahar Bayat,Michel Halimi Jean,Aurore Wolak,Stéphanie Gentile,Bénédicte Devictor,Elisabeth Monnet,Denis Boucaut Maitre,Mathieu Nacher,Véronique Merle,Jean-Philippe Jais,Jean-Pierre Daures,Alain Vergnenegre,Carole Loos-Ayav,Sylvie Merle,Marc Hazzan,Shirley Gervolino,Jean-Michel Nguyen,Silvia Iacobelli

Publisher

Elsevier BV

Subject

Nephrology

Reference28 articles.

1. IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT);Thaunat;Kidney Int,2020

2. Factors associated with COVID-19-related death using OpenSAFELY;Williamson;Nature,2020

3. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology;Quintaliani;J Nephrol,2020

4. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19;Ng;Kidney Int,2020

5. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe;Jager;Kidney Int,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3